Results
|
1.
|
|
|
2.
|
|
|
3.
|
Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice. [electronic resource] by
- Chen, Xiao-Wen
- Du, Xiao-Yan
- Wang, Yu-Xian
- Wang, Jian-Cheng
- Liu, Wen-Ting
- Chen, Wen-Jing
- Li, Hong-Yu
- Peng, Fen-Fen
- Xu, Zhao-Zhong
- Niu, Hong-Xin
- Long, Hai-Bo
Producer: 20161219
In:
Mediators of inflammation vol. 2016
Availability: No items available.
|
|
4.
|
Corrigendum to "Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF- [electronic resource] by
- Chen, Xiao-Wen
- Du, Xiao-Yan
- Wang, Yu-Xian
- Wang, Jian-Cheng
- Liu, Wen-Ting
- Chen, Wen-Jing
- Li, Hong-Yu
- Peng, Fen-Fen
- Xu, Zhao-Zhong
- Niu, Hong-Xin
- Long, Hai-Bo
Publication details: Mediators of inflammation
In:
Mediators of inflammation vol. 2016
Availability: No items available.
|
|
5.
|
Metadherin facilitates podocyte apoptosis in diabetic nephropathy. [electronic resource] by
- Liu, Wen-Ting
- Peng, Fen-Fen
- Li, Hong-Yu
- Chen, Xiao-Wen
- Gong, Wang-Qiu
- Chen, Wen-Jing
- Chen, Yi-Hua
- Li, Pei-Lin
- Li, Shu-Ting
- Xu, Zhao-Zhong
- Long, Hai-Bo
Producer: 20170828
In:
Cell death & disease vol. 7
Availability: No items available.
|
|
6.
|
Cyclopropanyldehydrocostunolide LJ attenuates high glucose-induced podocyte injury by suppressing RANKL/RANK-mediated NF-κB and MAPK signaling pathways. [electronic resource] by
- Chen, Xiao-Wen
- Liu, Wen-Ting
- Wang, Yu-Xian
- Chen, Wen-Jing
- Li, Hong-Yu
- Chen, Yi-Hua
- Du, Xiao-Yan
- Peng, Fen-Fen
- Zhou, Wei-Dong
- Xu, Zhao-Zhong
- Long, Hai-Bo
Producer: 20180221
In:
Journal of diabetes and its complications vol. 30
Availability: No items available.
|